As proteosome inhibition has proven to be effective in the treatment of certain cancers, we first investigated whether MG-132 would sensitize NB7 cells re-expressing caspase-8 (NB7+Casp8 cells) to TRAIL-induced apoptosis. The gene discussed is CASP8; the disease is cancer.